Skip to main content

and
  1. No Access

    Chapter

    Synaptic Dysfunction in Huntington’s Disease

    Huntington’s disease (HD) is a progressive, inherited, neurodegenerative disorder characterised by movement abnormalities, cognitive impairments and emotional disturbance (Bates et al. 2002). The genetic mutation...

    Dervila Glynn, A. Jennifer Morton in Folding for the Synapse (2011)

  2. No Access

    Article

    Choosing an animal model for the study of Huntington's disease

  3. Animal models of Huntington's disease (HD), which have been established in species that range from worms, fruitflies, mice and rats to pigs, sheep and monkeys,...

  4. Mahmoud A. Pouladi, A. Jennifer Morton, Michael R. Hayden in Nature Reviews Neuroscience (2013)

  5. Article

    Erratum to: Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington’s Disease Mice

    Sandor Kantor, Janos Varga, Shreya Kulkarni, A. Jennifer Morton in Neurotherapeutics (2017)

  6. Article

    Open Access

    Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington’s Disease Mice

    Disturbance of rapid eye movement (REM) sleep appears early in both patients with Huntington’s disease (HD) and mouse models of HD. Selective serotonin reuptake inhibitors are widely prescribed for patients wi...

    Sandor Kantor, Janos Varga, Shreya Kulkarni, A. Jennifer Morton in Neurotherapeutics (2017)

  7. Article

    Open Access

    Wake-Promoting and EEG Spectral Effects of Modafinil After Acute or Chronic Administration in the R6/2 Mouse Model of Huntington’s Disease

    Huntington’s disease (HD) is characterised by progressive symptoms including cognitive deficits and sleep/wake disturbances reflected in an abnormal electroencephalography (EEG). Modafinil, a wake-promoting an...

    Szilvia Vas, Jackie M. Casey, Will T. Schneider, Lajos Kalmar in Neurotherapeutics (2020)